Growth and Tolerance of Infants Fed Milk-Based Infant Formula

NACompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

June 8, 2019

Primary Completion Date

May 29, 2020

Study Completion Date

May 29, 2020

Conditions
Gastro-Intestinal Tolerance
Interventions
OTHER

Control Infant Formula

Ready to feed infant formula, feed ad libitum

OTHER

Experimental Infant Formula

Ready to feed infant formula, feed ad libitum

OTHER

Reference Group

Human milk, breast feeding ad libitum

Trial Locations (19)

32829

University Clinical Research-Deland, LLC a/b/a Accel Clinical Research, Orlando

33165

Phoenix Medical Research LLC, Miami

37660

Holston Medical Group, Kingsport

38116

Midsouth Center for Clinical Research, Memphis

40356

Michael W. Simon, M.D., PSC, Nicholasville

42303

Springs Medical Research, Owensboro

44060

Institute of Clinical Research, LLC, Mentor

44130

The Cleveland Pediatric Research Center, LLC, Middleburg Heights

47725

Deaconess Clinic, Inc., Evansville

75093

Plano Pediatrics - ACRC Trials, Plano

76104

Ventavia Research Group, LLC, Fort Worth

76248

Ventavia Research Group, LLC 3078, Keller

77008

Ventavia Research Group, Houston

77584

Kagan Pediatrics - HD Research Corporation, Pearland

78726

ARC Clinical Research at Wilson Parke, Austin

83404

Clinical Research Prime, Idaho Falls

85712

Watching Over Mothers & Babies, Tucson

95815

Pediatric Medical Associates, Sacramento

06360

Norwich Pediatric Group, P.C., Norwich

All Listed Sponsors
lead

Abbott Nutrition

INDUSTRY

NCT03967132 - Growth and Tolerance of Infants Fed Milk-Based Infant Formula | Biotech Hunter | Biotech Hunter